152 related articles for article (PubMed ID: 10626249)
21. Enhancement of susceptibility to Fas-mediated apoptosis of TH1 cells by nonmitogenic anti-CD3epsilon F(ab')2.
Yu XZ; Anasetti C
Transplantation; 2000 Jan; 69(1):104-12. PubMed ID: 10653388
[TBL] [Abstract][Full Text] [Related]
22. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function.
Daniel PT; Oettinger U; Mapara MY; Bommert K; Bargou R; Dörken B
Eur J Immunol; 1997 Apr; 27(4):1029-34. PubMed ID: 9130660
[TBL] [Abstract][Full Text] [Related]
23. Receptor-specific regulation of B-cell susceptibility to Fas-mediated apoptosis and a novel Fas apoptosis inhibitory molecule.
Rothstein TL; Zhong X; Schram BR; Negm RS; Donohoe TJ; Cabral DS; Foote LC; Schneider TJ
Immunol Rev; 2000 Aug; 176():116-33. PubMed ID: 11043772
[TBL] [Abstract][Full Text] [Related]
24. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition.
Zaks TZ; Chappell DB; Rosenberg SA; Restifo NP
J Immunol; 1999 Mar; 162(6):3273-9. PubMed ID: 10092779
[TBL] [Abstract][Full Text] [Related]
25. IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation.
Nakanishi K; Matsui K; Kashiwamura S; Nishioka Y; Nomura J; Nishimura Y; Sakaguchi N; Yonehara S; Higashino K; Shinka S
Int Immunol; 1996 May; 8(5):791-8. PubMed ID: 8671668
[TBL] [Abstract][Full Text] [Related]
26. Unique site of autoantibody production in Fas-deficient mice.
Jacobson BA; Foote LC; Panka DJ; Ju ST; Rothstein TL; Marshak-Rothstein A
Ann N Y Acad Sci; 1997 Apr; 815():218-29. PubMed ID: 9186658
[TBL] [Abstract][Full Text] [Related]
27. Fas (CD95, APO-1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells.
Cardier JE; Schulte T; Kammer H; Kwak J; Cardier M
FASEB J; 1999 Nov; 13(14):1950-60. PubMed ID: 10544178
[TBL] [Abstract][Full Text] [Related]
28. Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system.
Cabaner C; Gajate C; Macho A; Muñoz E; Modolell M; Mollinedo F
Br J Pharmacol; 1999 Jun; 127(4):813-25. PubMed ID: 10433487
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP.
Wang J; Lobito AA; Shen F; Hornung F; Winoto A; Lenardo MJ
Eur J Immunol; 2000 Jan; 30(1):155-63. PubMed ID: 10602037
[TBL] [Abstract][Full Text] [Related]
30. Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack.
Maher S; Toomey D; Condron C; Bouchier-Hayes D
Immunol Cell Biol; 2002 Apr; 80(2):131-7. PubMed ID: 11940113
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand.
von Bernstorff W; Spanjaard RA; Chan AK; Lockhart DC; Sadanaga N; Wood I; Peiper M; Goedegebuure PS; Eberlein TJ
Surgery; 1999 Jan; 125(1):73-84. PubMed ID: 9889801
[TBL] [Abstract][Full Text] [Related]
32. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
Deng C; Goluszko E; Christadoss P
J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
[TBL] [Abstract][Full Text] [Related]
33. Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes.
Ferrarini M; Imro MA; Sciorati C; Heltai S; Protti MP; Pellicciari C; Rovere P; Manfredi AA; Rugarli C
Int J Cancer; 1999 May; 81(4):573-9. PubMed ID: 10225447
[TBL] [Abstract][Full Text] [Related]
34. Trypanosoma cruzi infection selectively renders parasite-specific IgG+ B lymphocytes susceptible to Fas/Fas ligand-mediated fratricide.
Zuñiga E; Motran CC; Montes CL; Yagita H; Gruppi A
J Immunol; 2002 Apr; 168(8):3965-73. PubMed ID: 11937553
[TBL] [Abstract][Full Text] [Related]
35. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity.
Stranges PB; Watson J; Cooper CJ; Choisy-Rossi CM; Stonebraker AC; Beighton RA; Hartig H; Sundberg JP; Servick S; Kaufmann G; Fink PJ; Chervonsky AV
Immunity; 2007 May; 26(5):629-41. PubMed ID: 17509906
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of CD95 (Fas/Apo-1) on T cells of patients with B-cell chronic lymphocytic leukemia.
Groneberg C; Pickartz T; Binder A; Ringel F; Srock S; Sieber T; Schoeler D; Schriever F
Exp Hematol; 2003 Aug; 31(8):682-5. PubMed ID: 12901972
[TBL] [Abstract][Full Text] [Related]
37. Fas-induced apoptosis in B cells.
Mizuno T; Zhong X; Rothstein TL
Apoptosis; 2003 Oct; 8(5):451-60. PubMed ID: 12975576
[TBL] [Abstract][Full Text] [Related]
38. Inducible resistance to Fas-mediated apoptosis in B cells.
Rothstein TL
Cell Res; 2000 Dec; 10(4):245-66. PubMed ID: 11191348
[TBL] [Abstract][Full Text] [Related]
39. Cell death induced by the Fas/Fas ligand pathway and its role in pathology.
Waring P; Müllbacher A
Immunol Cell Biol; 1999 Aug; 77(4):312-7. PubMed ID: 10457197
[TBL] [Abstract][Full Text] [Related]
40. Fas receptor (CD95)-mediated apoptosis in leukemic cells.
Komada Y; Sakurai M
Leuk Lymphoma; 1997 Mar; 25(1-2):9-21. PubMed ID: 9130610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
